Groowe Groowe / Newsroom / TEVA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TEVA News

Teva Pharmaceutical Industries Limited American Depositary Shares

7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036

globenewswire.com
SNY REGN AMGN AZN GSK NVS TEVA

Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036

globenewswire.com
ABBV ALC APLS BHC JNJ PFE REGN TEVA VTRS

Teva to Present at the Upcoming Investor Conferences in March

globenewswire.com
TEVA

Medincell to Present at the TD Cowen 46 th Annual Healthcare Conference in Boston, March 2-4, 2026

businesswire.com
TEVA

Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

businesswire.com
TEVA

Medincell : La FDA américaine accepte le dossier de demande de mise sur le marché déposé par Teva pour l’Olanzapine LAI

businesswire.com
TEVA

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

globenewswire.com
TEVA

Dactinomycin Market Research Report 2026-2030 & 2035: $7.83 Billion Market Driven by Expansion of Cancer Centers, Emphasis on Pediatric Oncology, and Combination Therapy Research

globenewswire.com
PFE TEVA

Interact Expands its Employee Experience Platform with New AI‑Native Features and Workday Integration

globenewswire.com
LW DPZ TEVA

$ORCL Fraud Allegations: Oracle Corporation 11% Stock Drop Triggers Securities Fraud Class Action, Investors Notified to Contact BFA Law by April 6 to Protect Your Rights Ready to Announce with Confidence?

newsfilecorp.com
ORCL TEVA